Cell signaling and transcriptional regulation of osteoclast lineage commitment, differentiation, bone resorption and diseases
Top Cited Papers
Open Access
- 20 January 2026
- journal article
- review article
- Published by Springer Nature in Cell Discovery
- Vol. 12 (1) , 6
Abstract
Osteoclasts are bone-resorbing cells that play a central role in normal bone remodeling and contribute to bone loss associated with pathological conditions such as osteoporosis, osteoarthritis, rheumatoid arthritis, periodontal disease, and bone metastases of cancer. The commitment, differentiation, and function of osteoclasts depend on the establishment of specific gene expression patterns orchestrated through a network of transcription factors, which are sequentially activated by osteoclastogenic signals. This review provides an updated overview of the roles of key signaling pathways (e.g., RANKL signaling, NF-κB signaling and Gα 13 signaling), transcription factors (e.g., PU.1, C/EBP-α, NFATc1 and IRF8), cytokines (e.g., TNF-α, IL-1β and IL-6), and epigenetic regulators (e.g., DNMT3a, EZH2 and ASXL1) in osteoclast lineage commitment, differentiation and bone resorption under both physiological and pathological inflammatory conditions, along with insights from corresponding mouse models. We described the mechanism by which osteoclast-mediated bone resorption occurs through extracellular acidification driven by osteoclast-specific proton pump subunits (e.g., ATP6i and ATP6v0d2), followed by matrix protein degradation mediated by cathepsin K and MMP-9. Additionally, this review examines the interplay among molecular mechanisms that regulate osteoclast differentiation and activation under pathological and inflammatory conditions, elucidates their roles in osteoclast hyperactivation-related human diseases, and provides a comprehensive framework for understanding these processes. Finally, it underscores potential novel therapeutic strategies for osteoclast-related skeletal lytic diseases and highlights perspectives for future investigations.Keywords
Funding Information
- Foundation for the National Institutes of Health (AR075735)
- Foundation for the National Institutes of Health (DE023813)
- Foundation for the National Institutes of Health (AR070135)
- Foundation for the National Institutes of Health (AG056438)
This publication has 423 references indexed in Scilit:
- Pleiotropic effects of a null mutation in the c-fos proto-oncogeneCell, 1992
- Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in miceCell, 1991
- MACROPHAGE COLONY STIMULATING FACTOR RESTORESIN VIVOBONE RESORPTION IN THEOP/OPOSTEOPETROTIC MOUSEEndocrinology, 1990
- The Bacillus subtilis outB gene is highly homologous to an Escherichia coli ntr-like geneJournal of Bacteriology, 1990
- Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse.Proceedings of the National Academy of Sciences, 1990
- The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogeneCell, 1990
- OSTEOBLASTIC CELLS ARE INVOLVED IN OSTEOCLAST FORMATIONEndocrinology, 1988
- Isolation of a recombinant copy of the gene encoding C/EBP.Genes & Development, 1988
- Regulation of Inducible and Tissue-Specific Gene ExpressionScience, 1987
- Differentiation kinetics of osteoclasts in the periosteum of embryonic bones in vivo and in vitroThe Anatomical Record, 1986